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Primary hyperparathyroidism is one of the commonest causes of hypercalcaemia.' Failure to remove all actively secreting parathyroid tissue at operation remains a significant problem in the field of parathyroid surgery.' Currently, assessment of success relies on a combination of surgical opinion, histological frozen section and serial measurements of serum total or ionised calcium. Frozen section gives no information on completeness of removal of actively secreting tissue while changes in serum calcium take more than 24 h to occur.
This study assessed the suitability of parathyroid hormone (PTH) as a marker for surgical success at parathyroidectomy. Alterations in PTH following removal of parathyroid tissue were compared with those of standard biochemical markers of parathyroid function.
Conventional whole-molecule immunoradiometric assay methods for PTH involve an overnight incubation and so are not suitable for use in intraoperative monitoring.l"
We have modified a commercially available immunoradiometric assay to achieve reliable PTH quantification using a 30 min incubation period. Such modification to the assay procedure allows a I h turnaround time for PTH measurement thereby permitting true intraoperative monitoring.
METHODS
The 'N-tact' immunoradiometric assay (IRMA) Correspondence: Dr M F Ryan. kit" (Incstar Inc, Winnersh, UK) was used throughout the study. The IRMA consists of two different polyclonal antibodies which are purified by affinity chromatography. The first antibody, specific for PTH 39-84, is bound to a solid phase (polystyrene beads). The second antibody is specific for PTH 1-34 and labelled with iodine-125. Samples are incubated simultaneously with both antibodies. Only those peptide sequences containing 1-34 and 39-84 contribute to the final result. Concentrations of intact PTH are directly proportional to the radioactivity measured.
We examined the effects of changes in tracer volume, sample volume, incubation temperature, and agitation on the binding characteristics of the assay. By optimising conditions which enhance antigen-antibody binding an incubation time of 30 min was sufficient to permit measurement of PTH in serum specimens.
The agitation frequency used in these experiments was 300 Hz. A thermostatted incubation block was mounted on an orbital agitator and the cuvettes inserted as required. Cuvettes were covered to reduce evaporation of reagents during incubation. The standard procedure for washing and counting the beads was followed. All tubes were counted for I min.
Increasing incubation temperature above 37°C results in loss of binding, probably due to loss of PTH or denaturation of the participating reagents. The inclusion of an agitation step in the incubation is the single most effective alteration to the standard method in terms of the enhancement of binding. The tube containing the mixture Optimisation of binding conditions produces the binding-curve shown in curve 8. Incubation time can be reduced to 30 min with no loss of sensitivity. Within assay coefficient of variation is 17% at 10 ng/L and 2% at 170 ng/L, The detection limit of the 30 min assay is 4 ng/L calculated as the mean of the zero standard + 3 standard deviations. The standard curve of the 30 min assay is linear up to at least 400 ng/L, No alteration occurred in creatinine, urea, calcium, albumin or phosphate levels in patients during parathyroidectomy. All patients included in this study had normal renal function.
The rate of disappearance of PTH from the circulation in nine patients following parathyroidectomy is shown in Fig. 2 . The halflife is 3--4min and PTH falls to the detection limit of assay (4 ng/L) within 20 min of removal of the actively secreting parathyroid tissue. An example of surgical failure of exploration is included with the surgical successes for comparison in Fig. 2 (upper curve).~2 
RESULTS
The standard binding curves for the PTH assay under various conditions of incubation are shown in Fig. 1 and Table I . Binding at 2 h under standard conditions (i.e. conditions recommended in the commercial 'N-tact' kit) is also shown (curve 2). Combination of 37°C, 400 ilL sample volume, 200 ilL tracer volume and agitation at and bead must be of sufficiently large internal diameter to permit the bead to swirl the reagents during agitation. Three millilitre spectrophotometer cuvettes were ideal at the volumes used. The performance characteristics of the rapid assay were examined.
Serial peripheral venous blood samples were taken from nine patients undergoing parathyroidectomy for parathyroid adenoma (7 patients) and hyperplasia (2 patients). Biochemical hyperparathyroidism had been documented prior to admission for surgery. PTH, calcium, phosphate, creatinine and urea were measured in all patients. A single patient had PTH, total calcium, ionized calcium and phosphate measured serially following parathyroidectomy.
A 'preoperative' sample was taken from the antecubital fossa just prior to deep surgical exploration of the neck but after the patient had been anaesthetised and the initial incision had been made to control for possible interference with PTH secretion by anaesthetic factors. The timing of further sampling began when the surgeon had completed his removal of tissue. FIGURE 1. Standard binding curves for PTH assay under the conditions described in Table 1 . All incubations were for 2 h except curve 9 (overnight). 
DISCUSSION
Parathyroid hormone is the ideal marker of surgical success in removal of overactive parathyroid tissue.' The parathyroid glands are the only site of secretion" and the short halflife, 5.7 ensures that alterations in serum levels of the hormone occur rapidly following removal of the PTH secreting tissue. In our series of nine patients, PTH falls to undetectable levels within 20 min of removal of parathyroid tissue (Fig. 2 ). No alteration occurred in any of the other biochemical indices of parathyroid function in this time period (Fig. 3 ).
Nussbaum and colleagues,' using another whole-molecule specific IRMA, have recently reported the use of intraoperative monitoring of PTH in the surgical management of hyperparathyroidism. Their method involves a 15 min incubation period and the lower limit of detection of their assay is 25 ngjL. The reference range for PTH in our laboratory using the standard 'Nvtact' IRMA method is 10-40 ng/L" rendering the use of a 15 min assay impractical.
Failure of localisation of actively secreting tissue at initial exploration or insufficient removal of tissue necessitates re-exploration of the patient at a later time. The second operation is technically more difficult and the costs of readmission are substantial. Surgical manipulation during operation may induce release of PTH into the circulation (Fig. 2) . This point was alluded to by Nussbaum and colleagues in their study' and such release would complicate the interpretation of postoperative PTH levels.
Parathyroid hormone measurement permits definitive conclusions about the success or failure of the operation and re-exploration, if required, can begin within an hour of sampling for PTH analysis if a rapid PTH assay is used. A considerable saving in cost is possible by reducing the length of inpatient stay .
A further advantage of rapid PTH over frozen section is that disappearance of PTH from the circulation provides definitive evidence of complete removal of active tissue whereas histology can only provide evidence of tissue type removed not of tissue left behind. We are currently investigating the potential usefulness of this assay in complementing surgical expertise in diagnosis and operative localisation of actively secreting parathyroid tissue. Comparison of the alterations in PTH with those of other biochemical indices of parathyroid function is shown in Fig. 3 . None of the other parameters measured change significantly in a sufficiently short time period to render them of value in intraoperative monitoring.
The relationship between rapid PTH assay and standard overnight method is shown in Fig. '4. The regression equation is y = O'049x -8,6, r = 0,981, P < 0·001. 
